Previous 10 | Next 10 |
NEW YORK , Feb. 23, 2020 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that on February 21, 2020 , a special committee of the Board of Directors of Spherix Incorporated ("Spherix") approved a distribution to Spherix stockholders of 70,000 shares of Hoth Therape...
NEW YORK , Jan. 21, 2020 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that it has redesigned the company's website ( www.spherix.com ) to illuminate the overall digital transformation and recently acquired anti-cancer therapeutics. The new digital platform will emph...
NEW YORK , Dec. 10, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that it has closed the CBM BioPharma, Inc. transaction and is working to develop these cancer drugs. Building on its successful investment in Hoth Therapeutics, Inc., Spherix now ...
NEW YORK , Nov. 27, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) announced today that additional patent coverage has been granted by the United States Patent & Trademark Office to the patent portfolio being acquired by Spherix, in the field of pancreatic cancer. P...
Ultra-thinly traded Hoth Therapeutics ( HOTH +36.3% ) is up on a 5x surge in volume, albeit on turnover of only 51K shares, on no apparent news. More news on: Hoth Therapeutics, Inc., Spherix Incorporated, Healthcare stocks news, Stocks on the move, Read more ...
October 21, 2019 Palm Beach, FL – October 21, 2019 – Acute myeloid leukemia (AML) is an orphan’s disease. The FDA defines an orphan’s disease as a condition that affects fewer than 200,000 people nationwide. Before the passage of rare disease laws in th...
NEW YORK , Oct. 17, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that its stock has been upgraded to a "buy" rating from a "hold" rating in a research note issued to investors by ValuEngine Inc. ( www.valuengine.com ). ValuEngine uses proprietary models to fore...
An Emerging Markets News Commentary ORLANDO, Fla., Oct. 16, 2019 (GLOBE NEWSWIRE) -- It is not often in the pages of the Emerging Markets Report do we get the opportunity to tell our readers that a Company is giving back roughly $425,000* worth of value to its shareholders. In fac...
Spherix Incorporated (NASDAQ: SPEX ) approved (Oct. 2, 2019) a distribution to Spherix stockholders of 0.1M shares of Hoth Therapeutics (NASDAQ: HOTH ) held by Spherix. Spherix stockholder will receive one share of Hoth common stock for every twenty-nine shares of Spherix common sto...
NEW YORK , Oct. 11, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that on October 2, 2019 , the Board of Directors of Spherix Incorporated ("Spherix") approved a distribution to Spherix stockholders of 100,000 shares of Hoth Therapeutics, Inc. ("Hoth") held by ...
News, Short Squeeze, Breakout and More Instantly...
AIkido Pharma Company Name:
SPEX Stock Symbol:
NASDAQ Market:
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, today announced that Hernan Levett, currently Chief Fin...
ALLSCHWIL, Switzerland, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, announced today that it will host a business update conference call on October 9, 2023, at 8.30am EDT. ...
Ad hoc announcement pursuant to Art. 53 LR Balixafortide, a potent CXCR4 inhibitor, to be evaluated for the treatment of pancreatic ductal adenocarcinoma (PDAC) Spexis closed capital commitments totaling USD $7.5 million supporting Phase 3 ColiFin ® program in cystic fi...